KR
50
10
LYB
32
2
MET
60
2
ALL
45
-3
BRK.B
42
2
OMC
53
3
GM
61
-4
T
45
3
GILD
50
13
PBI
30
7
MRK
66
3
SO
70
-3
FCX
47
-9
CB
58
-2
GPS
57
-3
HCA
55
2
K
30
-2
HAL
41
11
HD
57
3
ICE
67
3
KR
50
10
LYB
32
2
MET
60
2
ALL
45
-3
BRK.B
42
2
OMC
53
3
GM
61
-4
T
45
3
GILD
50
13
PBI
30
7
MRK
66
3
SO
70
-3
FCX
47
-9
CB
58
-2
GPS
57
-3
HCA
55
2
K
30
-2
HAL
41
11
HD
57
3
ICE
67
3
Financhill
Back

M&T Bank Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
49

MTB
M&T Bank

Last Price:
147.60
Seasonality Move:
1.82%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
49
M&T Bank (MTB) is a Sell

Is M&T Bank a Buy, Sell or Hold?

  • The current M&T Bank [MTB] share price is $147.51. The Score for MTB is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • MTB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MTB Stock Price Chart

What is M&T Bank's stock price today?

  • The M&T Bank share price today is $147.51
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MTB is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

MTB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.68 Sell
Relative Strength Index (14 RSI): 52.01 Buy
Chaikin Money Flow: 941978 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (144.07 - 151.41) Sell
Bollinger Bands (100): (137.06 - 148.88) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

MTB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 144.57 Buy
20-day SMA: 146.38 Buy
50-day SMA: 146.89 Buy
200-day SMA: 135.44 Buy
8-day EMA: 145.9 Buy
20-day EMA: 146.43 Buy
50-day EMA: 146.09 Buy
200-day EMA: 139.83 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

M&T Bank Earnings Growth & MTB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, an increase next quarter of $0.28 per share, a decrease this year of $1.80 per share, and an increase next year of $2.07 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

M&T Bank Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):